Correlation Between Aarti Drugs and Ortel Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aarti Drugs and Ortel Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarti Drugs and Ortel Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aarti Drugs Limited and Ortel Communications Limited, you can compare the effects of market volatilities on Aarti Drugs and Ortel Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarti Drugs with a short position of Ortel Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarti Drugs and Ortel Communications.

Diversification Opportunities for Aarti Drugs and Ortel Communications

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aarti and Ortel is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Aarti Drugs Limited and Ortel Communications Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ortel Communications and Aarti Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarti Drugs Limited are associated (or correlated) with Ortel Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ortel Communications has no effect on the direction of Aarti Drugs i.e., Aarti Drugs and Ortel Communications go up and down completely randomly.

Pair Corralation between Aarti Drugs and Ortel Communications

Assuming the 90 days trading horizon Aarti Drugs Limited is expected to under-perform the Ortel Communications. But the stock apears to be less risky and, when comparing its historical volatility, Aarti Drugs Limited is 1.34 times less risky than Ortel Communications. The stock trades about -0.05 of its potential returns per unit of risk. The Ortel Communications Limited is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  158.00  in Ortel Communications Limited on September 29, 2024 and sell it today you would earn a total of  65.00  from holding Ortel Communications Limited or generate 41.14% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aarti Drugs Limited  vs.  Ortel Communications Limited

 Performance 
       Timeline  
Aarti Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Ortel Communications 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ortel Communications Limited are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Ortel Communications displayed solid returns over the last few months and may actually be approaching a breakup point.

Aarti Drugs and Ortel Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aarti Drugs and Ortel Communications

The main advantage of trading using opposite Aarti Drugs and Ortel Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarti Drugs position performs unexpectedly, Ortel Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ortel Communications will offset losses from the drop in Ortel Communications' long position.
The idea behind Aarti Drugs Limited and Ortel Communications Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like